Riskpilot← Back to searchSign inGet full accessSared Aktiebolag
ABActiveOrg 5563224137Stakagården 3Medical specialists activities · NACE 8622Est. 19881 employees
Revenue 2024
SEK 2K
-100% vs 2023
EBITDA margin
-10868.6%
-336% vs 2023
Equity ratio
80.2%
Financial strength
Net profit 2024
SEK 121K
-60% vs 2023
| Revenue | SEK 2K | -100% |
| EBITDA | SEK -185K | -336% |
| Net profit | SEK 121K | -60% |
| Total assets | SEK 3,6M | -6% |
| Equity | SEK 2,9M | -3% |
| Employees | 1 | — |
Legal name
Sared Aktiebolag
Org number
5563224137
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
31 mars 1988
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva ögonvård samt idka jordbruks- och skogs- näring och därmed förenlig verksamhet.
Address
Stakagården 3
Email
sven.redin@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 104 | 1 102 | 768 | 482 | 2 |
| Staff expenses | — | — | −208 | −215 | −85 |
| EBITDA | 492 | 477 | 318 | 78 | −185 |
| Depreciation & amort. | −251 | −145 | −148 | −113 | −67 |
| EBIT | 241 | 332 | 171 | −35 | −252 |
| Net financials | 9 | 21 | 104 | 366 | 289 |
| Profit before tax | 370 | 307 | 282 | 329 | 159 |
| Tax | −81 | −65 | −82 | −30 | −38 |
| Net profit | 289 | 242 | 200 | 300 | 121 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 871 | 3 847 | 4 069 | 3 859 | 3 641 |
| Equity | 2 559 | 2 700 | 2 900 | 3 000 | 2 921 |
| Long-term debt | 498 | 317 | 356 | 97 | 151 |
| Short-term debt | 212 | 182 | 173 | 121 | 50 |
| Total debt | 710 | 499 | 529 | 217 | 200 |
EBITDA margin
-10868.6%
This company
15.8%
Market median
-68889% vs market
20202024
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
4.1%
This company
18.4%
Market median
-78% vs market
20202024
Net profit margin
7114.3%
This company
8.1%
Market median
+87731% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Sared Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Britta Kristina Redin | Deputy Board Member | 0 companies |
| Sven Vilhelm Redin | Board of Directors | 0 companies |